Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eiger BioPharmaceuticals, Inc. has filed 694 SEC EDGAR filings since 05 Oct 2004

SEC filing history

Showing 676-687 of 687 matching filings.

Per page
25
Current page
28
S-1 File 333-191688

FORM S-1

Filing date
11 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
03 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-00304

DRS filing

Filing date
06 Sep 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-172955

D/A filing

Filing date
08 May 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-172955

D filing

Filing date
06 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-170592

D filing

Filing date
22 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-168810

D filing

Filing date
16 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-167978

D filing

Filing date
28 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-165275

D filing

Filing date
01 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-162710

D filing

Filing date
12 Jul 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-149731

D filing

Filing date
28 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .